Position in NTRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,175,891
-$1,917,400 QoQ
Shares Held
30,881
-12.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Brevan Howard Capital Management LP holds $32,347,391 across 20 Diagnostics & Research names. NTRA ranks #1 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
This page
|
30,881 | $6,175,891 | |
| 2 | QGEN |
Qiagen N.V.
|
133,177 | $5,332,407 | |
| 3 | DHR |
Danaher Corp /De/
|
21,586 | $4,092,705 | |
| 4 | A |
Agilent Technologies, Inc.
|
35,679 | $4,066,692 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
|
170,928 | $2,372,480 | |
| 6 | RVTY |
Revvity, Inc.
|
26,071 | $2,284,080 | |
| 7 | SHC |
Sotera Health Co
|
127,142 | $1,823,216 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
7,723 | $1,317,080 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,175,891 | 30,881 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,093,291 | 35,328 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $952,781 | 5,919 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $392,278 | 2,322 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $14,329,631 | 90,522 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,197,899 | 9,436 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $338,950 | 3,706 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||